FI852522L - Menetelmä tymopentiinianalogien valmistamiseksi - Google Patents

Menetelmä tymopentiinianalogien valmistamiseksi

Info

Publication number
FI852522L
FI852522L FI852522A FI852522A FI852522L FI 852522 L FI852522 L FI 852522L FI 852522 A FI852522 A FI 852522A FI 852522 A FI852522 A FI 852522A FI 852522 L FI852522 L FI 852522L
Authority
FI
Finland
Prior art keywords
preparation
thymopentin
analogs
thymopentin analogs
splenin
Prior art date
Application number
FI852522A
Other languages
English (en)
Swedish (sv)
Other versions
FI92325B (fi
FI852522A0 (fi
FI92325C (fi
Inventor
Gideon Goldstein
George Heavner
Daniel Kroon
Tapan Audhya
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of FI852522A0 publication Critical patent/FI852522A0/fi
Publication of FI852522L publication Critical patent/FI852522L/fi
Publication of FI92325B publication Critical patent/FI92325B/fi
Application granted granted Critical
Publication of FI92325C publication Critical patent/FI92325C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/66Thymopoietins
    • C07K14/662Thymopoietins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/18Thymus derived hormone or factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Control Of Eletrric Generators (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Charge By Means Of Generators (AREA)
  • Control Of Combustion (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI852522A 1984-06-27 1985-06-26 Menetelmä tymopentiinianalogien valmistamiseksi FI92325C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/625,344 US4629723A (en) 1984-06-27 1984-06-27 Potent thymopentin analogs
US62534484 1984-06-27

Publications (4)

Publication Number Publication Date
FI852522A0 FI852522A0 (fi) 1985-06-26
FI852522L true FI852522L (fi) 1985-12-28
FI92325B FI92325B (fi) 1994-07-15
FI92325C FI92325C (fi) 1994-10-25

Family

ID=24505633

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852522A FI92325C (fi) 1984-06-27 1985-06-26 Menetelmä tymopentiinianalogien valmistamiseksi

Country Status (14)

Country Link
US (2) US4629723A (fi)
EP (1) EP0166612B1 (fi)
JP (1) JPH0689029B2 (fi)
KR (1) KR920006563B1 (fi)
AT (1) ATE81135T1 (fi)
AU (1) AU592309B2 (fi)
CA (1) CA1269499A (fi)
DE (1) DE3586697T2 (fi)
DK (1) DK171238B1 (fi)
FI (1) FI92325C (fi)
IL (1) IL75637A (fi)
NO (1) NO167924C (fi)
NZ (1) NZ212461A (fi)
ZA (1) ZA854832B (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0215805A1 (en) * 1985-01-18 1987-04-01 MERCK PATENT GmbH Immunoregulatory peptides
DE3619633A1 (de) * 1986-06-11 1987-12-17 Hoechst Ag Peptide mit einfluss auf die diurese und natriurese, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
HUT46044A (en) * 1986-11-21 1988-09-28 Richter Gedeon Vegyeszet Process for producing immunstimulant peptides inhibiting multiplication of leukaemic cells and pharmaceutics comprising same
IT1216908B (it) * 1987-03-19 1990-03-14 Eniricerche Spa Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche.
HU199878B (en) * 1987-06-19 1990-03-28 Berlin Chemie Veb Process for producing acylated splenopentynes and pharmaceutical compositions comprising such compounds as active ingredient
US5656601A (en) * 1987-06-19 1997-08-12 Berlin-Chemie Ag Acylated splenopentins, methods for their synthesis and their use
RU2023448C1 (ru) * 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
WO1989009229A1 (en) * 1988-03-31 1989-10-05 Immunobiology Research Institute, Inc. Treatment of hiv viremic patients with thymopentin
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
US4943477A (en) * 1988-09-27 1990-07-24 Mitsubishi Rayon Co., Ltd. Conductive sheet having electromagnetic interference shielding function
WO1990003180A1 (en) * 1988-09-30 1990-04-05 Immunobiology Research Institute, Inc. Peptides having t cell suppressor activity
US5218089A (en) * 1988-12-23 1993-06-08 Sclavo S.P.A. Retro-inverso analogues of thymopentin and the method for their synthesis
IT1227908B (it) * 1988-12-23 1991-05-14 Eniricerche S P A Milano Sclav Nuovi analoghi retro-inversi della timopentina, il metodo per la loro sintesi ed il loro impiego per la preparazione di composizioni farmaceutiche
US5036050A (en) * 1989-01-12 1991-07-30 Immunobiology Research Institute, Inc. Compositions containing thymopentin for topical treatment of skin disorders
WO1992013546A1 (en) * 1991-02-04 1992-08-20 George Washington University Mb-40 peptide that enhances the production of interleukin-1 and modulates age-associated immune response
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
US5215964A (en) * 1991-06-03 1993-06-01 Immunobiology Research Institute, Inc. Peptides useful in regulating the immune and nervous systems
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
AU6770794A (en) * 1993-04-23 1994-11-21 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
FR2741076B1 (fr) 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
CN101168560B (zh) * 2006-10-23 2012-09-05 江苏正大天晴药业股份有限公司 N-取代肽酰胺,其药物组合物与用途
CN116850307A (zh) * 2021-12-16 2023-10-10 江西中医药大学 一种多肽tp-6在制备肿瘤诊断和/或治疗试剂中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4077949A (en) * 1973-12-28 1978-03-07 Sloan-Kettering Institute For Cancer Research Polypeptide hormones of the thymus
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
SE446867B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
US4261886A (en) * 1980-03-13 1981-04-14 Ortho Pharmaceutical Corporation Peptides having thymopoietin-like activity
CA1157466A (en) * 1979-04-12 1983-11-22 Gideon Goldstein Peptides having thymopoietin-like activity
JPS55149237A (en) * 1979-04-12 1980-11-20 Ortho Pharma Corp Thymopoietin active peptide
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4309340A (en) * 1980-03-31 1982-01-05 American Home Products Corporation Polypeptide compositions
US4361673A (en) * 1980-09-19 1982-11-30 American Home Products Corporation Polypeptide compositions
US4305852A (en) * 1980-10-20 1981-12-15 American Home Products Corporation Polypeptide compositions
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
DE3421614A1 (de) * 1984-06-09 1985-12-12 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von pentapeptiden mit wirkung auf das immunsystem und zwischenprodukte dieses verfahrens

Also Published As

Publication number Publication date
NZ212461A (en) 1988-10-28
FI92325B (fi) 1994-07-15
DK171238B1 (da) 1996-08-05
DK289285D0 (da) 1985-06-26
IL75637A (en) 1990-02-09
CA1269499A (en) 1990-05-22
ZA854832B (en) 1987-02-25
JPS6118799A (ja) 1986-01-27
US4629723A (en) 1986-12-16
EP0166612A3 (en) 1987-08-05
DK289285A (da) 1985-12-28
AU4421585A (en) 1986-01-02
DE3586697T2 (de) 1993-02-11
IL75637A0 (en) 1985-10-31
JPH0689029B2 (ja) 1994-11-09
NO167924B (no) 1991-09-16
KR860000314A (ko) 1986-01-28
KR920006563B1 (ko) 1992-08-08
AU592309B2 (en) 1990-01-11
FI852522A0 (fi) 1985-06-26
NO167924C (no) 1991-12-27
NO852567L (no) 1985-12-30
FI92325C (fi) 1994-10-25
ATE81135T1 (de) 1992-10-15
EP0166612A2 (en) 1986-01-02
USRE34165E (en) 1993-01-19
DE3586697D1 (en) 1992-11-05
EP0166612B1 (en) 1992-09-30

Similar Documents

Publication Publication Date Title
FI852522L (fi) Menetelmä tymopentiinianalogien valmistamiseksi
EP0165033A3 (en) Conformationally restricted thymopentin-like compounds
ES8607732A1 (es) Procedimiento para producir un preparado implantable de un peptido regulador, uno de sus analogos o una de sus sales fisiologicamente compatibles.
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
ATE58529T1 (de) Verfahren zur herstellung von 2,2,6,6,-tetraalkyl-4-piperidylamine.
IT8421622A0 (it) Procedimento per la preparazione di peptidi.
AU566133B2 (en) New polypeptide from thymus glands
DE3886213D1 (de) Verfahren zur Herstellung von Antioxidant-Zubereitungen.
NO165490C (no) Fremgangsmaate for spaltning av 1-aminoindan.
IT1176404B (it) Procedimento per la produzione di l-amminoacidi da alfa-chetoacidi
IT8567535A1 (it) Procedimento per la preparazione di amminoidrossicefamcarbossilati.
NO874888L (no) Fremgangsmaate til fremstilling av aminometyl-5,6,7,8-tetrahydronaftyloksyeddiksyrer.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
EP0179412A3 (en) Antigenic peptide compounds
EP0235904A3 (en) Treatment of allergy with thymopentin
DE3868875D1 (de) Apparat zur produktion von halbleitern.
IT8321507A0 (it) Procedimento di preparazione fermentativa di l-leucina.
ES8401320A1 (es) "un procedimiento para preparar composiciones farmaceuticas a base de sales de teofilina y aminoacidos basicos".
DE3689997D1 (de) Verfahren zur Herstellung von Maltose-Derivaten.
ATE69240T1 (de) Mitogene peptide.
MX26640A (es) Procedimiento para la preparacion de novedosos derivados de alquilendiamina.
IT1201898B (it) Procedimento per la decorazione di prodotti ottenuti per sublimazione, particolarmente per sci
ATE33828T1 (de) Verfahren zur herstellung von 1-hydroxylierten vitamin d derivaten.
ATE36314T1 (de) Verfahren zur herstellung von alpha,alphadifluoralkyl-phenylaether-derivaten.
NO882077L (no) Nytt system for administrasjon av liposomer til pattedyr.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: ORTHO PHARMACEUTICAL CORPORATION

MA Patent expired